Literature DB >> 22427787

The dilemma between efficacy as defined by regulatory bodies and effectiveness in clinical practice.

Gerd Glaeske.   

Abstract

Mesh：

Year:  2012        PMID： 22427787      PMCID： PMC3301971          DOI： 10.3238/arztebl.2012.0115

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  [Health services research: essential for allocation decisions - joint statement].

Authors:  H Pfaff; H Abholz; G Glaeske; A Icks; M Klinkhammer-Schalke; G Nellessen-Martens; E A M Neugebauer; C Ohmann; M Schrappe; H-K Selbmann; R Stemmer
Journal:  Dtsch Med Wochenschr       Date:  2011-10-12       Impact factor: 0.628

Review 2.  Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma.

Authors:  Hans-Georg Eichler; Francesco Pignatti; Bruno Flamion; Hubert Leufkens; Alasdair Breckenridge
Journal:  Nat Rev Drug Discov       Date:  2008-09-12       Impact factor: 84.694

Review 3.  Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers.

Authors:  Hans-Georg Eichler; Brigitte Bloechl-Daum; Eric Abadie; David Barnett; Franz König; Steven Pearson
Journal:  Nat Rev Drug Discov       Date:  2010-02-26       Impact factor: 84.694

4.  New drugs: evidence relating to their therapeutic value after introduction to the market.

Authors:  Mariam Ujeyl; Claudia Schlegel; Siegbert Walter; Ursula Gundert-Remy
Journal:  Dtsch Arztebl Int       Date:  2012-02-17       Impact factor: 5.594
  4 in total
  4 in total

1.  [Drug assessment: IQWiG, G-BA, and an international comparison].

Authors:  G Glaeske
Journal:  Internist (Berl)       Date:  2016-01       Impact factor: 0.743

2.  [Health services research in urology: basis and examples].

Authors:  G Glaeske
Journal:  Urologe A       Date:  2014-12       Impact factor: 0.639

3.  Reduce mortality risk above all else: a discrete-choice experiment in acute coronary syndrome patients.

Authors:  Axel C Mühlbacher; Susanne Bethge
Journal:  Pharmacoeconomics       Date:  2015-01       Impact factor: 4.981

4.  What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.

Authors:  Axel Mühlbacher; Susanne Bethge
Journal:  Eur J Health Econ       Date:  2015-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.